• Users Online: 238
  • Print this page
  • Email this page
Year : 2022  |  Volume : 21  |  Issue : 2  |  Page : 100-103

Cardiovascular health in turner syndrome: Manifestations, endocrine, and metabolic risk factors with a look at clinical practice

1 Department of Pediatrics, Al-Mustansiriyah University, College of Medicine, Baghdad, Iraq
2 Department of Medicine, College of Medicine, Al-Mustansiriyah University, Baghdad, Iraq
3 Department of Obstetrics and Gynecology, College of Medicine, Al-Nahrain University, Baghdad, Iraq

Correspondence Address:
Dr. Wasnaa Hadi Abdullah
Department of Pediatrics, Al-Mustansiriyah University, College of Medicine, Baghdad
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/mj.mj_13_22

Rights and Permissions

Turner syndrome (TS) is the most frequent female chromosomal abnormality, with a higher overall mortality rate than the general population; cardiovascular events are a significant risk factor. Cardiovascular manifestations in TS include congenital heart diseases, in addition to acquired heart diseases such as acute aortic dissection, stroke, myocardial infarction, and hypertension. Growth hormone-insulin growth factor 1 axis abnormality, estrogen hormone deficiency, liability for diabetes mellitus, and dyslipidemia all are endocrine risk factors affecting cardiovascular health in TS. Heart anatomical defects should be closely monitored for progression and associated complications throughout the patient's lifetime by a skilled cardiologist.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded114    
    Comments [Add]    

Recommend this journal